摘要
Disulfiram (DSF) has proven to be a promising anti-tumor drug in preclinical studies. However, its anti-cancer mechanism has not yet been elucidated. As an activator in tumor metastasis, N-myc downstream regulated gene-1 (NDRG1) is involved in multiple oncogenic signaling pathways and is upregulated by cell differentiation signals in various cancer cell lines. DSF treatment results in a significant reduction in NDRG1, while downregulated NDRG1 has a pronounced effect on invading cancer cells, as shown in our previous work. Here, in vitro and in vivo experiments confirm that DSF contributes to regulating tumor growth, EMT, and the migration and invasion of cervical cancer. Furthermore, our results show DSF binds to the ATP-binding pocket in the Nterminal domain of HSP90A, thereby affecting the expression of its client protein NDRG1. To our knowledge, this is the first report of DSF binding to HSP90A. In conclusion, this study sheds light on the molecular mechanism by which DSF inhibits tumor growth and metastasis through the HSP90A/NDRG1/& beta;-catenin pathway in cervical cancer cells. These findings provide novel insights into the mechanism underlying DSF function in cancer cells.
学科与关键词
- Quantitative proteomics analysis reveals novel insights into mechanisms of action of disulfiram (DSF)Zheng, Peng*; Liu, Chenglinzi; Wu, Yaoqin; Xu, Ruifeng; Chen, Ying; Hu, Fan; Chen, Zhuo*; Zhang, Tongcun*Proteomics Clinical Applications, 2022, 16(1): e2100031.被引 1
- Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viabilityYang, Xiao-Mei; Wu, Zheng; Wang, Xiaoqi; Zhou, Yaoqi; Zhu, Lei; Li, Dongxue; Nie, Hui-Zhen; Wang, Ya-Hui; Li, Jun*; Ma, Xueyun*BMC Pharmacology & Toxicology, 2022, 23(1): 54.被引 1
- Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancerTang, Bin; Wu, Min; Zhang, Lin; Jian, Shuyi; Lv, Shiyi; Lin, Tongyuan; Zhu, Shuangshuang; Liu, Layang; Wang, Yixue; Yi, Zhengfang*; Jiang, Feiyun*Frontiers in Oncology, 2023, 13: 1154073.被引 2
